Dietary soy isoflavone induced increases in antioxidant and eNOS gene expression lead to improved endothelial function and reduced blood pressure in vivo Katharina Mahn * , Consuelo Borrás § , Greg A. Knock ‡ , Paul Taylor † , Imran Y. Khan † , David Sugden † , Lucilla Poston † , Jeremy P. T. Ward ‡ , Richard M. Sharpe || , Jose Viña § , Philip I. Aaronson ‡ and Giovanni E. Mann * ,1 * Cardiovascular Division, † Reproductive Health, Endocrinology and Development Division, ‡ Asthma, Allergy and Lung Biology Division, School of Biomedical and Health Sciences and School of Medicine, King’s College London, London, UK; § Departamento de Fisiologia, Facultad de Medicina, Universidad de Valencia, Valencia, Spain; and || Medical Research Council Human Reproductive Sciences Unit, Centre for Reproductive Biology, Edinburgh, Scotland, UK 1 Correspondence: Cardiovascular Division, School of Biomedical and Health Sciences, King’s College London, Guy’s Campus, London SE1 1UL, UK. E-mail: giovanni.mann@kcl.ac.uk <h3>SPECIFIC AIMS</h3> The cardiovascular risks associated with hormone replacement therapy in postmenopausal women have precipitated a search for alternative estrogen receptor modulators. Genistein, a major isoflavone in soy protein, binds to estrogen receptor ß (ERß) with much higher affinity than
/lp/fed-of-american-socs-for-experimental-biology/dietary-soy-isoflavone-induced-increases-in-antioxidant-and-enos-gene-K0JmVomWNr